D. Chin

发表

Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.

G. Mills, A. Ullrich, Y. Yarden, 1992, Cancer research.

AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival

J. Testa, A. Gudkov, S. Bacus, 2002, Oncogene.

Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.

P. V. van Diest, J. Baak, S. Bacus, 1991, Laboratory investigation; a journal of technical methods and pathology.

Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus.

M. Zeremski, A. Gudkov, E. Komarova, 1997, Cancer research.

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

G. Hortobagyi, L. Pusztai, A. Buzdar, 2009, Pathology Oncology Research.

HER4 Expression Correlates with Cytotoxicity Directed by a Heregulin-Toxin Fusion Protein (*)

H. P. Fell, B. D. Cohen, G. Plowman, 1995, The Journal of Biological Chemistry.

Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.

Y. Yarden, D. Page, S. Bacus, 1994, The American journal of pathology.

HER-2/neu oncogene expression and proliferation in breast cancers.

J. Bacus, S. Bacus, D. Weinberg, 1990, The American journal of pathology.

Prostate Adenocarcinoma: An Image Analysis Technique for DNA Ploidy Determination

J. V. Bacus, J. Bacus, S. Bacus, 1993 .

Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen

S. Bacus, E. Huberman, K. Kiguchi, 1990, Molecular carcinogenesis.

Transgenic mice with p53‐responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo

G. Stark, A. Gudkov, E. Komarova, 1997, The EMBO journal.

Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.

R. Lupu, A. Gudkov, E. Peles, 1993, Cancer research.

Biological grading of breast cancer using antibodies to proliferating cells and other markers.

J W Bacus, J. Bacus, S. Bacus, 1989, The American journal of pathology.

HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer.

S. Bacus, D. Weinberg, R. K. Stern, 1992, Analytical and quantitative cytology and histology.

Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.

Y. Yarden, D. Stern, S. Bacus, 1996, The American journal of pathology.

Nucleus-irradiated Cells Is Cell Cycle Regulated and Determined by the γ Intracellular Localization of p 53 Tumor Suppressor Protein in Updated

M. Zeremski, A. Gudkov, E. Komarova, 2006 .

A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.

R. Lupu, S. Bacus, M. Lippman, 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins

G. Hortobagyi, W. Maltzman, S. Bacus, 2004, British Journal of Cancer.

Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.

Y. Yarden, M. Nikiforov, N. Hynes, 1996, Oncogene.

Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.

P. V. van Diest, J. Baak, S. Bacus, 1991, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.